The document discusses the approval of the drug AZT to treat AIDS in 1987. It describes how early clinical trials showed AZT significantly reduced deaths among AIDS patients compared to a control group. However, statistical analysis was needed to determine if the results were due to the drug or chance. Statistical tests found the probability the results were due to chance was less than 1 in 1000. Armed with this evidence, the FDA approved AZT after only 21 months of testing.